Global Healthcare Conference in London

17-20 November 2025 | The Waldorf Hilton

Registration is Closed

Days
Hours
Minutes
Seconds
#JefferiesHealthcare

Join Jefferies, our partners and leading global, public and private companies from the biotechnology, pharmaceuticals, medical technology, and healthcare services sectors

icon-handshake

This year’s gathering marks the sixteenth anniversary of the largest healthcare-dedicated conference in Europe.

icon-meeting

Join us to address near and long-term investment opportunities as well as the current trends driving healthcare in the U.S. and the world.

2025 Agenda / #JefferiesHealthcare

Panels and workshops
One on one meetings
Networking

Already registered? Download the Jefferies Conferences & Events app. Available in the Apple Store or Google Play

Full agenda will be available closer to the event.

Thank You to Our Sponsors

  • Healthcare
    September 2025
    $2,000,000,000
    Sale to Lotus Pharmaceutical
    Joint Financial Advisor
  • Healthcare
    April 2025
    Undisclosed
    Sale to KKR
    Joint Financial Advisor
  • Healthcare
    July 2025
    Undisclosed
    Majority Sale to EQT
    Sole Financial Advisor
  • Healthcare
    July 2025
    Undisclosed
    Investment by Bain Capital, Kohlberg and Mubadala Investment Company
    Lead Financial Advisor
  • Healthcare
    December 2024
    Undisclosed
    Acquisition of Synthon
    Joint Financial Advisor
  • Healthcare
    August 2025
    $750,000,000
    Convertible notes offering
    Joint Bookrunner
  • Healthcare
    March 2025
    $2,200,000,000
    Sale to and Subsequent Merger with Advanced Instruments
    Sole Financial Advisor
  • Healthcare
    September 2025
    $8,000,000,000
    Sale to Genmab
    Sole Financial Advisor
  • Healthcare
    August 2025
    Undisclosed
    Sale to CapVest
    Joint Lead Financial Advisor
  • Healthcare
    June 2025
    $9,500,000,000
    Sale to Sanofi
    Lead Financial Advisor
  • Healthcare
    January 2025
    $14,630,000,000
    Sale to Johnson & Johnson
    Joint Financial Advisor
  • Healthcare
    November 2025
    $259,000,000
    Common Stock Offering
    Lead Left Bookrunner
  • Healthcare
    October 2025
    $316,000,000
    Common Stock Offering
    Lead Left Bookrunner
  • Healthcare
    October 2025
    $288,000,000
    Common Stock Offering
    Lead Left Bookrunner
  • Healthcare
    October 2025
    $150,000,000
    Common Stock Offering
    Lead Left Bookrunner
  • Healthcare
    October 2025
    $120,000,000
    Private Placement of Equity
    Lead Placement Agent
  • Healthcare
    September 2025
    $288,000,000
    Common Stock Offering
    Lead Left Bookrunner
  • Healthcare
    September 2025
    $144,000,000
    Convertible Notes Offering
    Lead Left Bookrunner
  • Healthcare
    June 2025
    $230,000,000
    Common Stock Offering
    Lead Left Bookrunner
  • Healthcare
    June 2025
    $230,000,000
    Common Stock Offering
    Joint Bookrunner
  • Healthcare
    June 2025
    $345,000,000
    Common Stock Offering
    Lead Left Bookrunner
  • Healthcare
    April 2025
    $300,000,000
    PIPE in support of reverse merger with Aerovate Therapeutics
    Lead Placement Agent
  • Healthcare
    March 2025
    $500,000,000
    Common Stock Offering
    Joint Bookrunner
  • Healthcare
    January 2025
    $403,000,000
    Common Stock Offering
    Joint Bookrunner
  • Healthcare
    December 2024
    $250,000,000
    Private Placement of Equity
    Lead Placement Agent
  • Healthcare
    October 2025
    €808,000,000
    Initial Public Offering
    Joint Bookrunner
  • Healthcare
    January 2025
    Undisclosed
    Acquisition of Medical Media Business from FUJIFILM Irvine Scientific
    Sole Financial Advisor
  • Healthcare
    January 2025
    Undisclosed
    Investment from TA Associates and Novo Holdings
    Sole Financial Advisor
  • Healthcare
    April 2025
    Undisclosed
    Sale of stake to Hellman & Friedman
    Joint Financial Advisor
  • Healthcare
    March 2025
    €250,000,000
    Preferred Equity Investment from Carlyle
    Sole Financial Advisor
  • Healthcare
    February 2025
    €404,000,000
    Initial Public Offering
    Joint Global Coordinator and
    Joint Bookrunner

2024 Conference Highlights

By the numbers

600+

Healthcare Companies

3500

Attendees

6000

Investor Meetings

2500+

Business-to-Business Meetings